MARTIN SHKRELI
Would love to hear some thoughts about his strategy and his new lifetime ban from the pharmaceutical industry.
Trending Content - Investment Banking Forum
| +221 | Why UBS Is the Worst Place to Start Your IB Career | 35 | 3h |
| +162 | ONLY THESE BANKS OR YOU STRUCK OUT | 41 | 3h |
| +65 | Firm Thinks I'm Lying About Offer | 20 | 1d |
| +59 | Indiana University Fraternity Pipelines | 36 | 2h |
| +50 | Rogo AI | 20 | 16h |
| +46 | Elite Boutique interview questions | 11 | 1h |
| +44 | Suspended for a Year | 19 | 11h |
| +39 | Stay at Weak Dealflow Team or Lateral? | 12 | 2d |
| +39 | UBS 2nd Year Analyst Q&A (2026) | 16 | 1h |
| +23 | 1st Half 2026 (1H26) RX IB & RX Co. Rankings | 16 | 15h |
Career Resources
Deleted
That’s what I’m saying I stg
Iure error ullam dolor. Omnis quae optio nam aliquam autem molestiae doloribus. Quaerat modi aut non error.
Alias aut minus repellat qui nisi a ipsam sint. Omnis quia ab a sint dolorem repudiandae.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...